Skip to main navigation Skip to search Skip to main content

Rethinking informed consent in phage therapy: why location and approach matter

  • Ran Nir-Paz
  • , Jean Paul Pirnay
  • , Tristan Ferry
  • , Zuzanna Drulis-Kawa
  • , Annika Y. Classen
  • , Antonia I. Scobie
  • , Rebecca Lester
  • , Eyal Katvan
  • , Sylvia Hafkemeyer
  • , Shawna McCallin
  • , Gina A. Suh
    • European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Non-traditional Antibacterial Therapy (ESGNTA)
    • Hadassah University Medical Center
    • Faculty of Medicine
    • Hospices Civils de Lyon
    • Université Claude Bernard Lyon 1
    • University of Wroclaw
    • Faculty of Medicine and University Hospital of Cologne
    • Royal Free London NHS Foundation Trust
    • Royal National Orthopaedic Hospital NHS Trust
    • University College London
    • Peres Academic Center
    • subsidiary of the German Cystic Fibrosis association Mukoviszidose e. V.
    • Balgrist University Hospital
    • Mayo Clinic College of Medicine and Science

    Research output: Contribution to journalComment/debate

    Original languageEnglish
    JournalClinical Microbiology and Infection
    DOIs
    Publication statusAccepted/In press - 2026

    Keywords

    • Compassionate use
    • Helsinki declaration
    • Informed consent
    • Magistral phage
    • Personalized therapy
    • Phage therapy

    Cite this